Professor & Chief
UT Southwestern Medical Center
Dallas, Texas, United States
Inderpal S. Sarkaria, M.D., M.B.A., FACS, is a Professor in the Department of Cardiovascular and Thoracic Surgery at UT Southwestern Medical Center. He serves as Chief of the Division of Thoracic Surgery and specializes in general thoracic surgery and thoracic oncology. His expertise includes surgical treatment of esophageal cancer, lung cancer, lung nodules and cancers metastatic to the lung, thymoma and other mediastinal tumors, chest wall tumors, malignant pleural mesothelioma, myasthenia gravis, giant paraesophageal hernias, diaphragm hernias and paralysis, benign and malignant tracheal and airway diseases, thoracic outlet syndrome, and other associated conditions of the chest. He also performs hiatal hernia and anti-reflux operations for GERD such as Nissen fundoplications, achalasia procedures such as peroral endoscopic myotomies and Heller myotomies, and re-operative esophageal surgery. Dr Sarkaria is certified by the American Board of Surgery and the American Board of Thoracic Surgery.
An internationally known academic thoracic surgical oncologist and expert in minimally invasive thoracic robotic surgery, Dr. Sarkaria has made significant contributions to the field of thoracic surgery and has an outstanding record of transformative scholarly research, instructional excellence, academic leadership, and proven clinical outcomes. As a surgeon-scientist, his academic efforts have had an impact in many focused areas, including lung cancer genomics, robotic thoracic surgery, and advanced imaging technologies in thoracic surgery.
Dr. Sarkaria has authored more than 100 peer-reviewed publications, with over 26 as first author, as well as more than 75 abstracts and more than 25 invited manuscripts and book chapters focusing on general thoracic surgery. He is a sought-after speaker and has delivered more than 90 lectures at home and abroad related to his research and expertise.
Disclosure information not submitted.
Esophageal Cancer: Current Advances and Controversies
Friday, January 24, 2025
9:45am – 11:45am PT